Boryung Corporation
003850 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003850005
- LEI:
- Country:
- South Korea
- Address:
- 서울 종로구 원남동 보령빌딩 66-21, 종로구
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 3.8 MB | ||
| 2025-08-08 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 17.3 KB | ||
| 2025-07-31 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.1 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 138.9 KB | ||
| 2025-06-12 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 16.6 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-05 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 29.0 KB | ||
| 2025-06-02 00:00 |
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
|
Korean | 10.2 KB | ||
| 2025-06-02 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 770.4 KB | ||
| 2025-05-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.4 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.2 MB | ||
| 2025-04-29 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.0 KB | ||
| 2025-04-25 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항
|
Korean | 16.8 KB | ||
| 2025-04-23 00:00 |
Prospectus
투자설명서
|
Korean | 4.0 MB |
Automate Your Workflow. Get a real-time feed of all Boryung Corporation filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Boryung Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Boryung Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops proprietary therapeutics for serious unmet needs in oncology and inflammation.
United States of America
INCY
United States of America
INCY
Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.
United Kingdom
INDV
United Kingdom
INDV
Develops live bacterial medicines to prevent rare, severe gut diseases in premature infants.
Sweden
IBT
Sweden
IBT
Develops kinase inhibitors to treat neurodegenerative diseases like Parkinson's.
United States of America
IKT
United States of America
IKT
Clinical-stage biopharma developing novel biologic therapies for life-threatening cancers.
United States of America
INBX
United States of America
INBX
Develops cannabinoid drugs for unmet medical needs and supplies rare cannabinoids for B2B wellness.
United States of America
INM
United States of America
INM
Develops immunotherapies reprogramming innate immunity for cancer, Alzheimer's, and inflammation.
United States of America
INMB
United States of America
INMB
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France
IPH
France
IPH
Develops research-driven anti-aging solutions for skin regeneration and hair follicle formation.
South Korea
344860
South Korea
344860
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America
INO
United States of America
INO